EXCLUSIVE LICENSE AGREEMENT by and between Arena Pharmaceuticals, Inc. (“Arena”) United Therapeutics Corporation (“UT”) DATED AS OF NOVEMBER 15, 2018Exclusive License Agreement • January 25th, 2019 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 25th, 2019 Company Industry JurisdictionTHIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is made as of November 15, 2018, by and between Arena Pharmaceuticals, Inc., a Delaware corporation (“Arena”), and United Therapeutics Corporation, a Delaware corporation (“UT,” and with Arena, each a “Party” and, together, the “Parties”).
EXCLUSIVE LICENSE AGREEMENT by and between Arena Pharmaceuticals, Inc. (“Arena”) United Therapeutics Corporation (“UT”) DATED AS OF NOVEMBER 15, 2018Exclusive License Agreement • January 25th, 2019 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 25th, 2019 Company Industry JurisdictionTHIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is made as of November 15, 2018, by and between Arena Pharmaceuticals, Inc., a Delaware corporation (“Arena”), and United Therapeutics Corporation, a Delaware corporation (“UT,” and with Arena, each a “Party” and, together, the “Parties”).